- Home
- FGEN vs FLUX Comparison
FGEN vs FLUX Comparison
Compare FGEN & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- FLUX
- Stock Information
- Founded
- FGEN 1993
- FLUX N/A
- Country
- FGEN United States
- FLUX United States
- Employees
- FGEN N/A
- FLUX N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- FLUX Industrial Machinery/Components
- Sector
- FGEN Health Care
- FLUX Miscellaneous
- Exchange
- FGEN Nasdaq
- FLUX Nasdaq
- Market Cap
- FGEN 45.0M
- FLUX 98.5M
- IPO Year
- FGEN 2014
- FLUX N/A
- Fundamental
- Price
- FGEN $11.14
- FLUX $6.18
- Analyst Decision
- FGEN Strong Buy
- FLUX Strong Buy
- Analyst Count
- FGEN 2
- FLUX 2
- Target Price
- FGEN $146.50
- FLUX $6.00
- AVG Volume (30 Days)
- FGEN 29.1K
- FLUX 633.7K
- Earning Date
- FGEN 11-11-2025
- FLUX 09-16-2025
- Dividend Yield
- FGEN N/A
- FLUX N/A
- EPS Growth
- FGEN N/A
- FLUX N/A
- EPS
- FGEN N/A
- FLUX N/A
- Revenue
- FGEN $7,346,000.00
- FLUX $66,434,000.00
- Revenue This Year
- FGEN N/A
- FLUX $8.23
- Revenue Next Year
- FGEN N/A
- FLUX $24.72
- P/E Ratio
- FGEN N/A
- FLUX N/A
- Revenue Growth
- FGEN N/A
- FLUX 9.22
- 52 Week Low
- FGEN $4.50
- FLUX $1.15
- 52 Week High
- FGEN $21.94
- FLUX $7.30
- Technical
- Relative Strength Index (RSI)
- FGEN 49.45
- FLUX 67.40
- Support Level
- FGEN $10.37
- FLUX $5.06
- Resistance Level
- FGEN $11.60
- FLUX $6.56
- Average True Range (ATR)
- FGEN 0.66
- FLUX 0.88
- MACD
- FGEN -0.08
- FLUX 0.01
- Stochastic Oscillator
- FGEN 46.20
- FLUX 71.81
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.